Medical Management of Trigeminal Neuralgia

Author:

Zhang Niushen1

Affiliation:

1. Stanford University, USA

Abstract

The first-line treatment of trigeminal neuralgia can be very effective, but side effects are often difficult for patients to tolerate. This chapter is a guide to the broad selection of medical therapies currently available for the treatment of trigeminal neuralgia which includes oral therapies and other non-surgical methods of treatment such as IV medications, nasal sprays, topical ointments, and injections. The discussion of each treatment includes discussion of its evidence in current literature, its proposed mechanism of action, its dosing and appropriate setting for clinical use, and its side effect profile.

Publisher

IGI Global

Reference76 articles.

1. Efficacy, safety, and tolerability of duloxetine in idiopathic trigeminal neuralgia.;K.Anand;Journal of the Indian Medical Association,2011

2. Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type A

3. Safety and Efficacy of Oxcarbazepine: Results of Randomized, Double-Blind Trials

4. Beydoun, A., Schmidt, D., & D’Souza, J. (2002). Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta-analysis of three double blind comparative trials. Neurology, 58(suppl 3).

5. TRIGEMINAL NEURALGIA: ITS TREATMENT WITH A NEW ANTICONVULSANT DRUG (G-32883)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3